Healthtech Investors & VC Firms in Asia-Pacific
838 firms in this list, with a median first check of $600K. 163 of them lead rounds. Generated from verified public data and updated continuously.
Partech Ventures
BerlinSeed–Late Stage$200K – $50M
62 people
Adams Street Partners
ChicagoSeed–Late Stage$150M – $750M
82 people
TPG
San FranciscoGrowth–Late Stage
74 people
Sagard Private Equity Canada
Toronto, OntarioGrowth–Late Stage
95 people
RTP Global
New YorkSeed–Series B$1M – $15M
41 people
LeapFrog Investments
LondonGrowth
86 people
Innovestor Ventures
HelsinkiPre-Seed–Growth$270K – $3.2M
29 people
Flucas Ventures
JupiterSeed–Series A$100K – $5M
1 person
Polaris Partners
BostonSeed–Growth$500K – $5M
48 people
Novo Holdings
CopenhagenPre-Seed–Late Stage$1.1M – $54M
47 people
ICONIQ
San FranciscoPre-Seed–Late Stage
16 people
Valor Capital Group
New YorkSeed–Growth$100K – $5M
34 people
SOSV
New YorkPre-Seed–Series B$30K – $550K
90 people
Sierra Ventures
San MateoPre-Seed–Series A$500K – $10M
26 people
VU Venture Partners
San FranciscoSeed–Series B$200K – $1M
40 people
Advent International
BostonSeries A–Late Stage$1.1B
62 people
Mundi Ventures
MadridSeed–Late Stage$540K – $10.8M
18 people
Sixth Street
San FranciscoPre-Seed–Late Stage$50M – $2.5B
81 people
MPM BioImpact
BostonPre-Seed–Late Stage$1M – $15M
50 people
Celesta Capital
Menlo ParkSeed–Late Stage$5M – $10M
33 people
Sofina
BrusselsSeed–Late Stage$100M – $300M
57 people
Premji Invest
Menlo ParkSeed–Late Stage
35 people
Clairvest Group Inc
TorontoGrowth–Late Stage$25M – $100M
58 people
Northleaf Capital Partners
LondonGrowth
68 people
Related lists
Investors & VC Firms in North America (13013)Investors & VC Firms in United States (12149)Investors & VC Firms in Europe (5511)Crypto & Web3 Investors & VC Firms (4820)Investors & VC Firms in Global (4182)SaaS Investors & VC Firms (3878)AI & Machine Learning Investors & VC Firms (3817)Fintech Investors & VC Firms (3738)Investors & VC Firms in Asia-Pacific (3570)Healthtech Investors & VC Firms (3445)
Data sourced from public filings and firms' own websites — see our methodology.













































































































